INBX logo

Inhibrx Biosciences, Inc. (INBX) Net Margin

Annual Net Margin:

N/A
December 31, 2024

Summary

  • INBX annual net profit margin is not available.

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

INBX Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-Time High

-244.55%
INBX annual net profit margin is currently at an all-time high

3-Year Low

-13.32K%
INBX annual net profit margin is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
INBX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 31, 2026
INBX next annual earnings announcement is scheduled for Mar 31, 2026

OtherINBXprofitability metrics

Annual Net Income

$1.69B
INBX annual net profit is $1.69 billion

Annual Revenue

$200.00K
INBX annual revenue is $200.00 thousand

Annual Gross Margin

-1042.50%
INBX annual gross profit margin is -1042.50%

Annual EPS

$116.58
INBX annual earnings per share is $116.58

Quarterly Net Margin:

N/A
September 30, 2025

Summary

  • INBX quarterly net profit margin is not available.

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

INBX Quarterly Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-Time High

-54.71%
INBX quarterly net profit margin is currently at an all-time high

3-Year Low

-287.74K%
INBX quarterly net profit margin is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
INBX previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 31, 2026
INBX next earnings announcement is scheduled for Mar 31, 2026

OtherINBXprofitability metrics

Quarterly Net Income

-$35.26M
INBX quarterly net profit is -$35.26 million

Quarterly Revenue

$0.00
INBX quarterly revenue is $0.00

Quarterly Gross Margin

-
INBX quarterly gross profit margin value is unknown

Quarterly EPS

-$2.28
INBX quarterly earnings per share is -$2.28

Net Margin Formula

Net Margin =  Net Income
Revenue ✕ 100%

Annual Net Margin

-
INBX annual net profit margin value is unknown

Annual Net Income

$1.69B
INBX annual net profit is $1.69 billion

Annual Revenue

$200.00K
INBX annual revenue is $200.00 thousand

INBX Net Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year--
3Y3 Years--
5Y5 Years--

INBX Net Margin Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year
5Y5-Year
All-TimeAll-Time

INBX Net Margin History

DateAnnualQuarterly
Jun 2025
-
-2204.15%(+95.4%)
Dec 2024
-
-47.87K%(+69.5%)
Dec 2023
-13.32K%(-101.0%)
-
Jun 2023
-
-156.84K%(+45.5%)
Mar 2023
-
-287.74K%(-1826.9%)
Dec 2022
-6625.27%(-477.3%)
-14.93K%(-17.5%)
Sep 2022
-
-12.71K%(-139.4%)
Jun 2022
-
-5306.89%(-55.4%)
Mar 2022
-
-3415.74%(-357.2%)
Dec 2021
-1147.62%
-747.14%(+8.9%)
Sep 2021
-
-820.57%(+63.6%)
Jun 2021
-
-2255.99%(-0.9%)
DateAnnualQuarterly
Mar 2021
-
-2235.11%(-251.6%)
Dec 2020
-594.35%(-5.1%)
-635.77%(-80.7%)
Sep 2020
-
-351.82%(+34.4%)
Jun 2020
-
-536.44%(+76.7%)
Mar 2020
-
-2304.24%(+62.3%)
Dec 2019
-565.27%(-36.0%)
-6106.74%(-140.5%)
Sep 2019
-
-2539.42%(-129.1%)
Jun 2019
-
-1108.50%(-1926.1%)
Mar 2019
-
-54.71%(+80.9%)
Dec 2018
-415.51%(-69.9%)
-
Jun 2018
-
-286.24%(+23.5%)
Mar 2018
-
-374.20%
Dec 2017
-244.55%
-

FAQ

  • What is the all-time high annual net margin for Inhibrx Biosciences, Inc.?
  • What is the all-time high quarterly net margin for Inhibrx Biosciences, Inc.?

What is the all-time high annual net margin for Inhibrx Biosciences, Inc.?

Inhibrx Biosciences, Inc. all-time high annual net profit margin is -244.55%

What is the all-time high quarterly net margin for Inhibrx Biosciences, Inc.?

Inhibrx Biosciences, Inc. all-time high quarterly net profit margin is -54.71%
On this page